The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20040662
Annacker et al.

Figure S1 Similar incidence and severity of CD4+CD45RBhi T cell-mediated colitis in Rag-/- and CD103-/-Rag-/- recipients.

Figure S2 Effect of chimeric anti-CD103 mAbs on the development of colitis in recipients of WT CD4+CD45RBhi T cells.

Figure S3 CD103 is not required for T reg cell-mediated suppression in vitro.

Figure S4 CD103+ DCs are present in the LP and isolated leukocytic clusters of protected and colitic mice.

Figure S5 Similar DC subset composition, distribution, and function in Balb/c Rag-/- and CD103-/-Rag-/- mice.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS